AAT Bioquest

mFluor™ UV 375 goat anti-mouse IgG (H+L) *Cross-Absorbed*

Ordering information
Catalog Number
Unit Size
Add to cart
Additional ordering information
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
ShippingStandard overnight for United States, inquire for international
Request quotation
Physical properties
Molecular weight~150 kDa
Spectral properties
Absorbance (nm)342
Correction Factor (260 nm)0.099
Correction Factor (280 nm)0.138
Extinction coefficient (cm -1 M -1)300001
Excitation (nm)351
Emission (nm)387
Quantum yield0.941
Storage, safety and handling
H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
StorageFreeze (< -15 °C); Minimize light exposure
Related products
mFluor™ Violet 450 SE
mFluor™ Violet 510 SE
mFluor™ Violet 540 SE
mFluor™ Blue 570 SE
mFluor™ Green 620 SE
mFluor™ Yellow 630 SE
mFluor™ Red 700 SE
mFluor™ Red 780 SE
mFluor™ Red 780 amine
mFluor™ Violet 450-VAD-FMK
mFluor™ 510-VAD-FMK
mFluor™ Violet 450-streptavidin conjugate
mFluor™ Violet 510-streptavidin conjugate
mFluor™ Violet 540-streptavidin conjugate
mFluor™ Blue 570-streptavidin conjugate
mFluor™ Green 620-streptavidin conjugate
mFluor™ Yellow 630-streptavidin conjugate
mFluor™ Red 700-streptavidin conjugate
mFluor™ Red 780-streptavidin conjugate
mFluor™ Violet 450-dUTP *1 mM in TE Buffer (pH 7.5)*
mFluor™ Violet 450 acid
mFluor™ Violet 510 acid
mFluor™ Violet 540 acid
mFluor™ Blue 570 acid
mFluor™ Green 620 acid
mFluor™ Yellow 630 acid
mFluor™ Red 700 acid
mFluor™ Violet 500 SE
mFluor™ UV375 SE
mFluor™ Red 780 acid
mFluor™ UV460 SE
mFluor™ Blue 630 SE
mFluor™ Blue 660 SE
mFluor™ Violet 610 SE
mFluor™ Green 630 SE
mFluor™ Blue 580 SE
mFluor™ Blue 590 SE
mFluor™ Blue 620 SE
mFluor™ Red 780 Maleimide
mFluor™ Violet 550 SE
mFluor™ Violet 505 SE
mFluor™ Violet 590 SE
mFluor™ Violet 545 SE
mFluor™ UV420 SE
mFluor™ UV455 SE
mFluor™ UV520 SE
mFluor™ UV540 SE
mFluor™ UV610 SE
mFluor™ Violet 450 Azide
mFluor™ Violet 450 maleimide
mFluor™ UV 375 Biotin Conjugate
mFluor™ UV 460 Biotin Conjugate
mFluor™ Violet 500 Biotin Conjugate
mFluor™ Violet 540 Biotin Conjugate
mFluor™ Red 780 Biotin Conjugate
mFluor™ Violet 530 SE
mFluor™ Violet 530 maleimide
mFluor™ Violet 480 SE
mFluor™ Blue 660 tyramide
mFluor™ Violet 450-PEG4-Biotin Conjugate
mFluor™ Violet 450-Wheat Germ Agglutinin (WGA) Conjugate
mFluor™ Violet 500-Wheat Germ Agglutinin (WGA) Conjugate
mFluor™ Violet 540-Wheat Germ Agglutinin (WGA) Conjugate
mFluor™ Blue 585 SE
mFluor™ Blue 583 SE
mFluor™ Blue 580 Styramide
mFluor™ Blue 630 Styramide
mFluor™ Blue 660 Styramide
mFluor™ Green 620 Styramide
mFluor™ Red 780 Styramide
mFluor™ Violet 540 Styramide
mFluor™ Violet 545 Styramide
mFluor™ Violet 610 Styramide
mFluor™ UV455-streptavidin conjugate
mFluor™ Violet 545-streptavidin conjugate
mFluor™ Violet 550-streptavidin conjugate
mFluor™ Violet 590-streptavidin conjugate
mFluor™ Violet 610-streptavidin conjugate
mFluor™ Violet 510 goat anti-mouse IgG (H+L)
mFluor™ Violet 510 goat anti-mouse IgG (H+L) *Cross-Absorbed*
mFluor™ Violet 510 goat anti-rabbit IgG (H+L)
mFluor™ Violet 510 goat anti-rabbit IgG (H+L) *Cross-Absorbed*
mFluor™ Red 780 goat anti-rabbit IgG (H+L) *Cross-Absorbed*
mFluor™ Red 780 goat anti-rabbit IgG (H+L)
mFluor™ Red 780 goat anti-mouse IgG (H+L) *Cross-Absorbed*
mFluor™ Red 780 goat anti-mouse IgG (H+L)
mFluor™ Blue 585 Anti-human CD4 Antibody *SK3*
mFluor™ UV420-streptavidin conjugate
mFluor™ Blue 615 SE
mFluor™ Green 615 SE
Show More (80)


Molecular weight
~150 kDa
Absorbance (nm)
Correction Factor (260 nm)
Correction Factor (280 nm)
Extinction coefficient (cm -1 M -1)
Excitation (nm)
Emission (nm)
Quantum yield
mFluor™ UV375 goat anti-mouse conjugates are secondary antibodies designed for optimal performance in immunoassay applications, including flow cytometry, immunofluorescence, and confocal microscopy. These conjugates consist of goat-derived polyclonal antibodies with high affinity and specificity towards mouse IgG, conjugated to the bright and stable mFluor™ UV375 fluorochrome. This conjugation is optimized to ensure minimal non-specific binding and enhanced signal clarity, with rigorous purification steps to remove unconjugated components. Provided in a ready-to-use format with a recommended dilution range, the conjugate undergoes stringent quality control tests for performance and specificity. Its compatibility with a wide range of mouse primary antibodies and the exceptional contrast provided by mFluor™ UV375 fluorescence makes it a reliable tool for detecting diverse target antigens in multicolor staining protocols. mFluor™ UV375 is optimally excited by the UV laser and emits maximally at 387 nm. These affinity-purified goat anti-mouse secondary antibodies are valuable for their versatility and sensitivity, enabling efficient detection, sorting, or purification of specific targets through effective signal amplification in research applications. To minimize cross-reactivity, these goat anti-mouse IgG whole antibodies have been cross-adsorbed against human, horse, mouse, and bovine IgG.


Open in Advanced Spectrum Viewer

Spectral properties

Absorbance (nm)342
Correction Factor (260 nm)0.099
Correction Factor (280 nm)0.138
Extinction coefficient (cm -1 M -1)300001
Excitation (nm)351
Emission (nm)387
Quantum yield0.941

Product Family

NameExcitation (nm)Emission (nm)Extinction coefficient (cm -1 M -1)Quantum yieldCorrection Factor (260 nm)Correction Factor (280 nm)
mFluor™ UV 375 goat anti-rabbit IgG (H+L)3513873000010.9410.0990.138
mFluor™ UV 375 goat anti-rabbit IgG (H+L) *Cross-Absorbed*3513873000010.9410.0990.138


View all 50 references: Citation Explorer
In-situ and amplification-free imaging of hERG ion channels at single-cell level using a unique core-molecule-shell-secondary antibody SERS nanoprobe.
Authors: Zhang, Wen-Shu and Liu, Xiao-Peng and Yue, Shuai and Wang, Ya-Ning and Wang, Yue and Xu, Zhang-Run
Journal: Talanta (2023): 123900
Use of immunoglobulin replacement therapy in patients with secondary antibody deficiency in daily practice: a European expert Q&A-based review.
Authors: Cinetto, Francesco and Francisco, Isabel Esteves and Fenchel, Klaus and Scarpa, Riccardo and Montefusco, Vittorio and Pluta, Andrzej and Wolf, Hermann M
Journal: Expert review of hematology (2023): 237-243
Recommendations for Management of Secondary Antibody Deficiency in Multiple Myeloma.
Authors: Giralt, Sergio and Jolles, Stephen and Kerre, Tessa and Lazarus, Hillard M and Mustafa, S Shahzad and Papanicolaou, Genovefa A and Ria, Roberto and Vinh, Donald C and Wingard, John R
Journal: Clinical lymphoma, myeloma & leukemia (2023): 719-732
Clinical outcomes of immunoglobulin treatment for patients with secondary antibody deficiency: Data from the Ontario immunoglobulin treatment case registry.
Authors: Abadeh, Armin and Shehadeh, Sarah and Betschel, Stephen and Waserman, Susan and Cameron, Donald William and Cowan, Juthaporn
Journal: PloS one (2023): e0294408
Development of recombinant secondary antibody mimics (rSAMs) for immunoassays through genetic fusion of monomeric alkaline phosphatase with antibody binders.
Authors: Park, Jiyeon and Bae, Yoonji and Eom, Soomin and Choi, Yuha and Lee, Giwook and Kang, Sebyung
Journal: International journal of biological macromolecules (2023): 126299
Endogenous complement-activating IgM is not required for primary antibody responses but promotes plasma cell differentiation and secondary antibody responses to a large particulate antigen in mice.
Authors: Palm, Anna-Karin E and Westin, Annika and Ayranci, Diyar and Heyman, Birgitta
Journal: Frontiers in immunology (2023): 1323969
[Immunglobulin Substitution Therapy in Hematological Patients with secondary Antibody Deficiency].
Authors: Braschler, Thomas R and Zeerleder, Sacha
Journal: Therapeutische Umschau. Revue therapeutique (2022): 295-300
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency.
Authors: Visentin, Andrea and Molinari, Maria Chiara and Pravato, Stefano and Cellini, Alessandro and Angotzi, Francesco and Cavaretta, Chiara Adele and Ruocco, Valeria and Imbergamo, Silvia and Piazza, Francesco and Proietti, Giulia and Mauro, Francesca Romana and Trentin, Livio
Journal: Current oncology (Toronto, Ont.) (2022): 274-283
Immunoglobulin substitution in patients with secondary antibody deficiency in chronic lymphocytic leukemia and multiple myeloma: a representative analysis of guideline adherence and infections.
Authors: Link, Hartmut and Kerkmann, Markus and Holtmann, Laura and , and ,
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2022): 5187-5200
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics.
Authors: Innocenti, Idanna and Tomasso, Annamaria and Benintende, Giulia and Autore, Francesco and Fresa, Alberto and Vuono, Florenzia and Stirparo, Luca and Galli, Eugenio and D'Arena, Giovanni and Sorà, Federica and Efremov, Dimitar and Laurenti, Luca
Journal: Hematological oncology (2022): 469-474